Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Biomerica Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q4 2021
- Shares held
- 2.52M
- +130.8K (+5.5%) vs. Q4 2021
- Total value
- $11.3M
- +$1.97M (+21.2%) vs. Q4 2021
- New holders
- 4
- 8 more added
- Sold out
- 0
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,308 | $6.00K | 0.00% | −203−13.4% | Reduced |
| UBS Group AG | 2,415 | $11.0K | 0.00% | +1,027+74.0% | Added |
| Morgan Stanley | 2,517 | $12.0K | 0.00% | +387+18.2% | Added |
| Bank of America Corp | 5,000 | $22.0K | 0.00% | +968+24.0% | Added |
| Wells Fargo & Company | 6,566 | $29.0K | 0.00% | +20.0% | Added |
| Simplex Trading, LLC | 9,091 | $40.0K | 0.00% | +9,091 | New |
| HCR Wealth Advisors | 10,000 | $45.0K | 0.01% | −10,000−50.0% | Reduced |
| Susquehanna International Group, LLP | 10,500 | $47.0K | 0.00% | −3,711−26.1% | Reduced |
| Orion Capital Management LLC | 11,500 | $51.0K | 0.03% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,812 | $57.0K | 0.00% | +12,812 | New |
| Raymond James Financial Services Advisors, Inc. | 13,662 | $61.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,391 | $82.0K | 0.00% | 00.0% | Unchanged |
| Emerald Advisers, LLC | 19,000 | $85.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 26,463 | $118.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 27,432 | $123.0K | 0.00% | −45,400−62.3% | Reduced |
| Perritt Capital Management Inc | 30,000 | $134.0K | 0.07% | 00.0% | Unchanged |
| GWM Advisors LLC | 32,900 | $147.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 32,810 | $147.0K | 0.00% | +32,810 | New |
| State Street Corp | 55,831 | $250.0K | 0.00% | +1,200+2.2% | Added |
| Ridgewood Investments LLC | 60,000 | $268.0K | 0.18% | +60,000 | New |
| Heritage Investors Management Corp | 69,350 | $310.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 77,249 | $345.0K | 0.00% | +3,179+4.3% | Added |
| Fore Capital, LLC | 85,000 | $380.0K | 0.45% | 00.0% | Unchanged |
| BlackRock Inc. | 183,925 | $821.0K | 0.00% | +1,414+0.8% | Added |
| Vanguard Group Inc | 545,951 | $2.44M | 0.00% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 1,169,841 | $5.23M | 0.13% | +67,268+6.1% | Added |